Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beilei Wang

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
Molecules (Basel, Switzerland)|December 11, 2022
SnSe Nanosheets Mimic Lactate Dehydrogenase to Reverse Tumor Acid Microenvironment Metabolism for Enhancement of Tumor TherapyHeng Wang, Beilei Wang, Jie Jiang, et al.
European Journal of Medicinal Chemistry|September 8, 2023
Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitorXiaofei Liang, Maoqing Deng, Fengming Zou, et al.
Journal of Nanobiotechnology|August 7, 2023
Brain-targeted nanoreactors prevent the development of organophosphate-induced delayed neurological damageShuaijun Zou, Qianqian Wang, Qian He, et al.
BMC Biology|May 19, 2026
Integrated genomics and transcriptomics reveal key events in pancreatic neuroendocrine neoplasmShiwei Guo, Xiaohan Shi, Xiaoyi Yin, et al.
European Journal of Medicinal Chemistry|October 12, 2023
Discovery of dihydropyridinone derivative as a covalent EZH2 degraderBin Zhou, Beilei Wang, Fengming Zou, et al.
Cell Reports|September 22, 2023
Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapyFang Xu, Dongpeng Jiang, Jialu Xu, et al.
Acta Pharmaceutica Sinica. B|March 7, 2020
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agentZongru Jiang, Li Wang, Xuesong Liu, et al.
Signal Transduction and Targeted Therapy|January 15, 2023
Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignanciesHusheng Mei, Hong Wu, Jing Yang, et al.
European Journal of Medicinal Chemistry|January 9, 2020
Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of PlasmodiumXiaofei Liang, Zongru Jiang, Zhenghui Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 10, 2022
Genetically Engineered Hematopoietic Stem Cells Deliver TGF-β Inhibitor to Enhance Bone Metastases ImmunotherapyBeilei Wang, Jinyu Bai, Bo Tian, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Molecules (Basel, Switzerland)|December 11, 2022
SnSe Nanosheets Mimic Lactate Dehydrogenase to Reverse Tumor Acid Microenvironment Metabolism for Enhancement of Tumor TherapyHeng Wang, Beilei Wang, Jie Jiang, et al.
European Journal of Medicinal Chemistry|September 8, 2023
Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitorXiaofei Liang, Maoqing Deng, Fengming Zou, et al.
Journal of Nanobiotechnology|August 7, 2023
Brain-targeted nanoreactors prevent the development of organophosphate-induced delayed neurological damageShuaijun Zou, Qianqian Wang, Qian He, et al.
BMC Biology|May 19, 2026
Integrated genomics and transcriptomics reveal key events in pancreatic neuroendocrine neoplasmShiwei Guo, Xiaohan Shi, Xiaoyi Yin, et al.
European Journal of Medicinal Chemistry|October 12, 2023
Discovery of dihydropyridinone derivative as a covalent EZH2 degraderBin Zhou, Beilei Wang, Fengming Zou, et al.
Cell Reports|September 22, 2023
Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapyFang Xu, Dongpeng Jiang, Jialu Xu, et al.
Acta Pharmaceutica Sinica. B|March 7, 2020
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agentZongru Jiang, Li Wang, Xuesong Liu, et al.
Signal Transduction and Targeted Therapy|January 15, 2023
Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignanciesHusheng Mei, Hong Wu, Jing Yang, et al.
European Journal of Medicinal Chemistry|January 9, 2020
Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of PlasmodiumXiaofei Liang, Zongru Jiang, Zhenghui Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 10, 2022
Genetically Engineered Hematopoietic Stem Cells Deliver TGF-β Inhibitor to Enhance Bone Metastases ImmunotherapyBeilei Wang, Jinyu Bai, Bo Tian, et al.
Pageof 18